These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT Population. Bocchi EA; Böhm M; Borer JS; Ford I; Komajda M; Swedberg K; Tavazzi L; Cardiology; 2015; 131(4):218-24. PubMed ID: 25968495 [TBL] [Abstract][Full Text] [Related]
29. Prediction of beneficial effect of beta blocker treatment in severe ischaemic cardiomyopathy: assessment of global left ventricular ejection fraction using dobutamine stress cardiovascular magnetic resonance. Kaandorp TA; Lamb HJ; Bax JJ; Boersma E; Viergever EP; van der Wall EE; de Roos A Heart; 2005 Nov; 91(11):1471-2. PubMed ID: 16230448 [No Abstract] [Full Text] [Related]
31. beta-blockers in heart failure--much more than heart rate reduction. Von Haehling S; Anker SD J Card Fail; 2002 Dec; 8(6):379-80. PubMed ID: 12528089 [No Abstract] [Full Text] [Related]
32. Carvedilol: use in chronic heart failure. Doughty RN; White HD Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454 [TBL] [Abstract][Full Text] [Related]
33. [Drug therapy of chronic heart failure: when are beta receptor blockers indicated?]. vom Dahl J; Schotten U; Sasse A Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S48-53. PubMed ID: 10535047 [No Abstract] [Full Text] [Related]
34. [Antihypertensive activity and effect on parameters of heart rate variability of beta-blockers carvedilol and metoprolol]. Praskurnichiĭ EA; Shevchenko OP; Makarova SV; Zhukova VA Kardiologiia; 2005; 45(11):17-23. PubMed ID: 16353059 [No Abstract] [Full Text] [Related]
35. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure. Metra M; Covolo L; Pezzali N; Zacà V; Bugatti S; Lombardi C; Bettari L; Romeo A; Gelatti U; Giubbini R; Donato F; Dei Cas L Cardiovasc Drugs Ther; 2010 Feb; 24(1):49-60. PubMed ID: 20352314 [TBL] [Abstract][Full Text] [Related]
36. [Beta-blocking drugs indicated in patients with heart failure]. Voors AA; van Gilst WH; van Veldhuisen DJ Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2457-9. PubMed ID: 14708208 [TBL] [Abstract][Full Text] [Related]
37. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC). Bergström A; Andersson B; Edner M; Nylander E; Persson H; Dahlström U Eur J Heart Fail; 2004 Jun; 6(4):453-61. PubMed ID: 15182771 [TBL] [Abstract][Full Text] [Related]
38. COMET: a proposed mechanism of action to explain the results and concerns about dose. Hjalmarson A; Waagstein F Lancet; 2003 Sep; 362(9389):1077; author reply 1077-8. PubMed ID: 14522544 [No Abstract] [Full Text] [Related]
39. [Is "COMET" pointing in the right direction?--Pro]. Hanrath P Dtsch Med Wochenschr; 2003 Dec; 128(50):2666. PubMed ID: 14673747 [No Abstract] [Full Text] [Related]
40. Effects of carvedilol on ventriculo-arterial coupling in patients with heart failure. Razzolini R; Tarantini G; Boffa GM; Orlando S; Iliceto S Ital Heart J; 2004 Jul; 5(7):517-22. PubMed ID: 15487269 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]